Myeloablative and immunosuppressive properties of treosulfan in mice

Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and Cyclophosphamide

George W. Santos, P. J. Tutschka, Ronald Brookmeyer et al. · New England Journal of Medicine · 1983 · 818 citations

Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen

PJ Tutschka, EA Copelan, JP Klein · Blood · 1987 · 539 citations · Full text

Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens.

Alan C. Braverman, Joseph H. Antin, Maureen Plappert et al. · Journal of Clinical Oncology · 1991 · 334 citations

Heart Failure, Transplantation Medicine, Cardiovascular Pharmacology +16

MYLERAN IN CHRONIC MYELOID LEUKÆMIA CHEMICAL CONSTITUTION AND BIOLOGICAL ACTION

Alexander Haddow, G. M. Timmis · The Lancet · 1953 · 214 citations

Inflammation, Hematological Malignancy, Hematology +5

Pharmacokinetic and metabolic studies of high-dose busulphan in adults

Moustapha Hassan, Göran Berg, Hans Ehrsson et al. · European Journal of Clinical Pharmacology · 1989 · 161 citations

Pharmacology, High-dose Busulphan, Pharmacotherapy +2